Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00061087
Status:
COMPLETED
Last Update Posted:
2019-04-23
First Post:
2003-05-21
Brief Title:
Treatment of Adult Attention Deficit Hyperactivity Disorder ADHD in Methadone Patients - 1
Sponsor:
New York State Psychiatric Institute
Organization:
New York State Psychiatric Institute
Study Overview
Official Title:
Treatment of Adult ADHD in Methadone Patients
Status:
COMPLETED
Status Verified Date:
2019-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to treat Adult Attention Deficit Hyperactivity Disorder ADHD in methadone patients
Detailed Description:
This project is a three armed double-blind placebo-controlled randomized trial comparing the efficacy of MPH and BPR relative to each other and to placebo for treating persistent ADHD in methadone-maintained patients One hundred and twenty subjects will be randomized to receive either MPH BPR or placebo with equal probability Randomization will be stratified by site and whether or not cocaine is also being used Efficacy will be measured by treatment retention reduction in illicit drug use and drug craving improvement of ADHD symptoms and overall functional status
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 4184R | OTHER | NYSPI IRB | httpsreporternihgovquickSearchR01DA011444 |
| R01DA011444 | NIH | None | None |